Powered by

Powered by Portfolio Grader

S&P Pharmaceuticals SPDR (XPH)

38.86 0.38 (0.97%) 20:00 EDT
XPH Stock Quote Delayed 15 Minutes

  • XPH Stock Chart

  • Historical XPH Prices

  
Dividend & Yield:       0.24 (0.62%)
P/E:       -
Market Cap:       297.29M
EPS:       -
Volume:       31,500
Day's Range:       38.80 - 39.09
52wk Range:       34.51 - 49.96
Quotes delayed at least 20 mins.
Historical Data for XPH
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
05/20/19 39.09 39.09 38.80 31,539 38.86 -0.38   -0.97%
05/17/19 39.22 39.72 39.05 31,700 39.24 -0.30   -0.76%
05/16/19 39.40 39.84 39.40 49,446 39.54 0.17   0.43%
05/15/19 38.98 39.44 38.81 38,095 39.37 0.11   0.28%
05/14/19 39.00 39.43 39.00 44,100 39.26 0.40   1.03%
05/13/19 39.75 39.75 38.64 194,773 38.86 -1.69   -4.17%
05/10/19 40.50 40.67 39.92 25,800 40.55 -0.15   -0.37%
05/09/19 40.13 40.73 39.84 75,618 40.70 0.38   0.94%
05/08/19 39.61 40.55 39.61 45,045 40.32 0.72   1.82%
05/07/19 40.73 40.75 39.40 68,021 39.60 -1.63   -3.95%
05/06/19 40.28 41.35 40.28 41,935 41.23 0.32   0.78%
05/03/19 40.40 40.93 40.39 28,600 40.91 0.65   1.61%
05/02/19 39.97 40.26 39.70 34,518 40.26 0.39   0.98%
05/01/19 39.92 40.32 39.61 62,000 39.87 0.05   0.13%
04/30/19 40.28 40.28 39.55 40,835 39.82 -0.57   -1.41%
04/29/19 40.21 40.61 40.21 56,292 40.39 0.21   0.52%
04/26/19 39.84 40.20 39.74 23,800 40.18 0.48   1.21%
04/25/19 39.40 39.79 39.13 45,562 39.70 0.28   0.71%
04/24/19 39.55 39.67 39.24 27,924 39.42 -0.18   -0.45%
04/23/19 38.98 39.82 38.87 76,690 39.60 0.66   1.69%
04/22/19 38.76 39.03 38.47 96,378 38.94 0.05   0.13%
04/18/19 38.96 39.11 38.24 84,800 38.89 0.01   0.03%
04/17/19 40.38 40.49 38.56 107,187 38.88 -1.37   -3.40%
04/16/19 40.84 40.84 40.19 31,226 40.25 -0.32   -0.79%
04/15/19 40.64 40.64 40.33 24,709 40.57 0.00   0.00%
04/12/19 41.00 41.11 40.44 121,600 40.57 -0.34   -0.83%
04/11/19 41.49 41.49 40.84 37,068 40.91 -0.56   -1.35%
04/10/19 41.46 41.56 41.39 36,098 41.47 0.01   0.02%
04/09/19 41.91 41.91 41.39 33,323 41.46 -0.80   -1.89%
04/08/19 42.29 42.30 42.01 29,086 42.26 0.00   0.00%
04/05/19 42.06 42.47 42.06 75,800 42.26 0.32   0.76%
04/04/19 41.69 41.98 41.63 58,033 41.94 0.24   0.58%
04/03/19 41.87 41.98 41.54 56,952 41.70 0.08   0.19%
04/02/19 41.65 41.81 41.54 26,185 41.62 -0.03   -0.07%
04/01/19 41.85 42.00 41.64 126,271 41.65 0.07   0.17%
03/29/19 41.41 41.67 41.30 36,000 41.58 0.31   0.75%
03/28/19 40.99 41.33 40.99 41,475 41.27 0.37   0.90%
03/27/19 41.23 41.29 40.56 39,407 40.90 -0.29   -0.70%
03/26/19 41.10 41.52 41.01 61,273 41.19 0.29   0.71%
03/25/19 41.20 41.23 40.65 67,689 40.90 -0.30   -0.73%
03/22/19 42.29 42.29 41.16 82,600 41.20 -1.19   -2.81%
03/21/19 41.88 42.59 41.88 56,151 42.39 0.35   0.83%
03/20/19 42.19 42.38 41.76 100,250 42.04 -0.26   -0.61%
03/19/19 42.07 42.40 42.07 62,415 42.30 0.31   0.74%
03/18/19 41.81 42.06 41.71 34,055 41.99 0.24   0.57%
03/15/19 41.79 41.90 41.62 58,700 41.75 0.02   0.05%
03/14/19 41.89 42.12 41.68 187,837 41.73 -0.23   -0.55%
03/13/19 41.70 42.03 41.65 81,314 41.96 0.45   1.08%
03/12/19 41.36 41.81 41.20 45,082 41.51 0.31   0.75%
03/11/19 41.04 41.31 40.74 24,685 41.20 0.24   0.59%
03/08/19 40.64 40.97 40.50 48,000 40.96 -0.02   -0.05%
03/07/19 41.06 41.28 40.75 113,757 40.98 -0.08   -0.19%
03/06/19 42.41 42.45 41.00 85,366 41.06 -1.41   -3.32%
03/05/19 42.75 42.84 42.19 87,547 42.47 -0.32   -0.75%
Download Data To Spreadsheet
S&P Pharmaceuticals SPDR (XPH) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

S&P Pharmaceuticals SPDR Stock Analysis

Rating:

Total Grade:

Analysis Breakdown

XPH Stock Grade:
Fundamental Grade:
Quantitative Grade:
XPH Earnings
Earnings Growth:
Earnings Momentum:
Earnings Surprises:
Analyst Earnings Revisions:
XPH Financial Information
Sales Growth:
Operating Margin Growth:
Cash Flow:
Return on Equity:

S&P Pharmaceuticals SPDR Stock: Weekly View

This Week:
Last Week:
Two Weeks Ago:
Get Full Report